Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol). (PATROL)

AstraZeneca

Status: Completed

Conditions: Hypertension; Hyperlipidemia; Glycemia

Study type: Observational

Funder types: Industry

Identifiers

NCT00891124

NIS-CKR-DUM-2009/2

Details and patient eligibility

About

This study will address the proportion of achievement patients in treatment target goal on glycemic control, hypertension and hyperlipidemia according to ADA 2008 guideline, among outpatients coming to the Korean primary care nationwide.

Enrollment: 4,045 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who had been diagnosed with type II diabetes mellitus
• Patients with hypertension and / or hyperlipidemia
• Patients who had agreed to Informed

Exclusion criteria

• Patients who had been diagnosed with type I diabetes mellitus
• Patients with neither hypertension and hyperlipidemia

Trial design

4,045 participants in 1 patient group

1

Description:

Type II DM and Hypertension and/or Hyperlipidemia